- Home
- KZIA vs BMHL Comparison
KZIA vs BMHL Comparison
Compare KZIA & BMHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KZIA | BMHL |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | Australia | Hong Kong |
| Employees | N/A | 9 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.9M | 155.4M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | KZIA | BMHL |
|---|---|---|
| Price | $12.35 | $5.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.50 | N/A |
| AVG Volume (30 Days) | ★ 163.3K | 1.9K |
| Earning Date | 06-04-2026 | 06-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $66.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.86 | $2.72 |
| 52 Week High | $17.40 | $6.35 |
Technical Indicators
Market Signals| Indicator | KZIA | BMHL |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 45.52 |
| Support Level | $11.90 | $3.19 |
| Resistance Level | $14.75 | $6.35 |
| Average True Range (ATR) | 1.07 | 0.29 |
| MACD | -0.10 | -0.11 |
| Stochastic Oscillator | 10.77 | 14.75 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About BMHL Bluemount Holdings Limited Class B Ordinary Shares
Bluemount Holdings Ltd through its operating subsidiaries, is a Hong Kong-based consulting and advisory, financial services, and luxury timepiece trading provider. The Company provides consulting and advisory services on business development strategies, including seeking suitable transaction projects for business development or diversification and suitable business partners or investors for fund-raising projects. Its services are centered around three core offerings: Business Transformation, Strategy, and Transactions. The Company also sources, buys, and sells brand-new luxury branded timepieces. It operates through two reportable segments: security-related services and asset management, and trading of timepieces, with the trading of timepieces generating maximum revenue.